Tanya L.

Tanya L. is an accomplished executive with extensive experience in global market access and strategy, currently serving as Executive Director at Madrigal Pharmaceuticals since May 2025. Previously, Tanya held the position of Director for Global Value Access & Strategy at Vertex Pharmaceuticals, where responsibilities included leading access strategies for treatments in various complex health conditions. As Director of US Value & Access for Dupixent at Sanofi Genzyme, Tanya developed comprehensive market access strategies. Earlier career highlights include roles at Simon-Kucher & Partners, where Tanya advised healthcare companies, and at the Massachusetts Institute of Technology, providing research contributions to drug development paradigms. Educational background includes a Master of Science from MIT and a Bachelor of Arts in Neuroscience from Pomona College, along with additional training from the University of Melbourne and Wharton Executive Education.